ASX-listed healthcare companies are increasingly teaming up with universities to fast-track new therapies, combining academic ...

A self-acupressure app helped nearly 60% of women with ovarian cancer no longer experience cancer-related fatigue.The MeTime app, which teaches individuals how to perform self-acupressure, ...

One of oncology’s biggest challenges is that the same treatment can work well for some patients but fail completely in others.

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others.

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration. The diagnostic ...

Preclinical evidence supports azenosertib ADC combinations as potential promising therapeutic strategies for Triple-Negative Breast Cancer ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in Nature Communications, by a multidisciplinary team ...

A discovery from Mayo Clinic researchers in Rochester shows a certain lung cancer treatment can also be used to treat aggressive cases of ovarian cancer. The study published by clinic researchers in ...

A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form ...

Ovarian cancer is considered the deadliest cancer affecting the female reproductive system. One of the main reasons it is so dangerous is that it is usually discovered very late. In many patients, ...